1. Home
  2. SCNX vs CPIX Comparison

SCNX vs CPIX Comparison

Compare SCNX & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scienture Holdings Inc.

SCNX

Scienture Holdings Inc.

HOLD

Current Price

$0.28

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$7.68

Market Cap

98.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCNX
CPIX
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
98.3M
IPO Year
2019
2007

Fundamental Metrics

Financial Performance
Metric
SCNX
CPIX
Price
$0.28
$7.68
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $1.50
N/A
AVG Volume (30 Days)
★ 609.4K
48.6K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 58.70
EPS
★ N/A
N/A
Revenue
$3,831,778.00
★ $42,010,949.00
Revenue This Year
$1,097.38
N/A
Revenue Next Year
$239.80
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 30.72
16.75
52 Week Low
$0.24
$1.85
52 Week High
$2.60
$9.28

Technical Indicators

Market Signals
Indicator
SCNX
CPIX
Relative Strength Index (RSI) 23.28 52.59
Support Level $0.24 $7.34
Resistance Level $0.43 $8.27
Average True Range (ATR) 0.02 0.46
MACD -0.01 0.12
Stochastic Oscillator 7.47 60.67

Price Performance

Historical Comparison
SCNX
CPIX

About SCNX Scienture Holdings Inc.

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: